BioGenes Berlin

New Tech Note: How to Overcome Cross Reactivity Towards Drug Substances


Discover the insights shared at the 11th annual BEBPA Host Cell Protein Conference held in Dubrovnik, Croatia. The conference featured a plethora of captivating talks and workshops centered around HCP analysis, ensuring attendees were at the forefront of industry advancements.

In case you missed BioGenes' participation in this prestigious event, we have compiled the essential details from the presentation of our Head of Immunoassay Development, Stefan Sommerschuh, into an exclusive tech note. It is called "How to overcome cross reactivity towards drug substances a process-specific HCP ELISA development for the Physcomitrium patens (Moss) Plant-Based Expression System." It delves into the techniques and strategies employed to tackle cross reactivity challenges in a process-specific HCP ELISA development.

Don't miss out on this opportunity to enhance your understanding of cutting-edge HCP analysis techniques.

Get your copy of the tech note


Keep me updated